Industry news
Adynxx Inc. merges with Alliqua Biomedical Inc.
Adynxx, Inc. a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, announced the completion of its merger with Alliqua BioMedical, Inc.
In connection with the merger, Alliqua has changed its name to Adynxx, Inc
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.